ArticleKorean journal of clinical oncology2021

Adjuvant chemotherapy for patients with stage II high-risk and III colon cancer: Hindering factors to adherence and impact on long-term survival.

Jieun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.